PMA supplement
P030031 S011: NAVISTAR & CELSIUS THERMOCOOL CATHETERS
FDA PMA supplement · Panel Track · Biosense Webster, Inc.
Key facts
| Original PMA | P030031 |
|---|---|
| Supplement number | S011 |
| Supplement type | Panel Track |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | NAVISTAR & CELSIUS THERMOCOOL CATHETERS |
| Generic name | Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation |
| Applicant | Biosense Webster, Inc. |
| Product code | OAE |
| Received date | Aug 13, 2008 |
| Decision date | Feb 6, 2009 |
| Docket number | 09M-0071 |
| Notice date | Feb 18, 2009 |
At a glance
- Yes Expedited review granted
- Yes Approval order on file
- Yes Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: